Yale professor under review says he’s "very glad" he wrote Epstein email

Yale removes Professor David Gelernter from class amid review over Jeffrey Epstein emails.
The Japan Times

From Coffee Waste to "Vegan Leather": Tsunan Sake Brewery’s Dr. Kengo Suzuki Explores the Frontiers of Fermentation with Indonesia’s Bell Living Lab

In a significant move bridging traditional Japanese craftsmanship with Southeast Asian deep-tech innovation, Dr. Kengo Suzuki, President of Tsunan Sake Brewery (Headquarters: Tsunan, Niigata) and CEO ...

Exasol AG (EXLGF) Discusses Preliminary Financial Results, Churn Impact, and Strategic Progress in Key Verticals Transcript

Discusses Preliminary Financial Results, Churn Impact, and Strategic Progress in Key Verticals February 3, 2026 8:00 AM ...
BMJ Global Health

Local systems, local solutions: which factors drive essential medicine availability in public health facilities across Indonesia?

Introduction Ensuring free access to essential medicines is a cornerstone of universal health coverage, yet many countries ...

Kimi K2.5 Agent Swarm : Spread Complex Jobs Across 100 Agents, Attack Tasks in Packs

Kimi K2.5 introduces a multi-agent orchestration with up to 100 workers, helping teams cut complex task time and boost ...
InfoQ

Uber Moves In-House Search Indexing to Pull-Based Ingestion in OpenSearch

Uber transitions its in-house search indexing to OpenSearch with a pull-based ingestion framework, improving reliability, ...

Indonesia identifies eight blocks with large rare earth reserve potential

JAKARTA, Feb 9 (Reuters) - Indonesia has identified eight mining blocks with large potential for rare earth elements and plans to launch two research projects to develop rare earth processing ...
Rock Paper Shotgun

Best Y-Level for Diamonds in Minecraft 1.21

Learn the best level for mining Diamonds in Minecraft 1.21, as well as tips on the best method for strip-mining, and other ...
ascopubs.org

Which is better in CD19 CAR-T treatment of r/r B-ALL, CD28 or 4-1BB? A parallel trial under the same manufacturing process.

First-in-human study of KHK2455, a long-acting, potent and selective indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor, in combination with mogamulizumab (Moga), an anti-CCR4 monoclonal antibody, in ...